Tech Company Financing Transactions
Wellpartner Funding Round
On 8/1/2008, Wellpartner raised $16.1 million in Series D funding from Burrill & Company, 3i Venture Capital and Integra Ventures.
Transaction Overview
Company Name
Announced On
8/1/2008
Transaction Type
Venture Equity
Amount
$16,100,000
Round
Series D
Investors
Burrill & Company (Lead Investor) (Caroline Kovac)
Integra Ventures (Hans Lundin)
Montlake Capital (Todd Marker)
Proceeds Purpose
Proceeds will be used to fund Wellpartner's strategic growth initiatives to expand mail order pharmacy fulfillment for commercial insurers and Medicaid plans and to grow the Company's retail contract pharmacy program for health care safety-net providers that participate in the federal 340B drug discount program.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
22 Cortlandt St. 17th Floor
New York, NY 10007
USA
New York, NY 10007
USA
Phone
Undisclosed
Website
Email Address
Overview
Wellpartner leverages technology to enhance the delivery of its pharmacy services at lower costs.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Vice President
James Love
VP - Client Services
Thomas Hagan
VP - Finance
Ken Bodmer
VP - Sales
Michael Majerik
Browse more venture capital transactions:
Prev: 7/31/2008: H2scan venture capital transaction
Next: 8/1/2008: Mobilization Labs venture capital transaction
Share this article
News on VC Transactions
We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs